Evidence map›Paper›PMID 29794037›Full record

ArticleJournal of lipid research2018

Sphingolipid changes do not underlie fatty acid-evoked GLUT4 insulin resistance nor inflammation signals in muscle cells.

Nicolas J Pillon, Scott Frendo-Cumbo, Maya R Jacobson, Zhi Liu, Paul L Milligan, Hai Hoang Bui, Juleen R Zierath, Philip J Bilan, Joseph T Brozinick, Amira Klip

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Thirty sweet years of GLUT4.The Journal of biological chemistry · 2019
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Nicolas J PillonDepartments of Physiology and Pharmacology Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-1107-9490
Scott Frendo-CumboProgram in Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada.
Maya R JacobsonProgram in Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada.
Zhi LiuProgram in Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada.
Paul L MilliganEli Lilly and Company, Indianapolis, IN.
Hai Hoang BuiEli Lilly and Company, Indianapolis, IN.
Juleen R ZierathDepartments of Physiology and Pharmacology Karolinska Institutet, Stockholm, Sweden.
Philip J BilanProgram in Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada.
Joseph T BrozinickEli Lilly and Company, Indianapolis, IN.
Amira KlipProgram in Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada amira@sickkids.ca.
Hospital for Sick Children · CAEli Lilly (United States) · USKarolinska Institutet · SE

Funding

Medical Research Council MR/K012126/1
6 · The paper itself

Abstract

Ceramides contribute to obesity-linked insulin resistance and inflammation in vivo, but whether this is a cell-autonomous phenomenon is debated, particularly in muscle, which dictates whole-body glucose uptake. We comprehensively analyzed lipid species produced in response to fatty acids and examined the consequence to insulin resistance and pro-inflammatory pathways. L6 myotubes were incubated with BSA-adsorbed palmitate or palmitoleate in the presence of myriocin, fenretinide, or fumonisin B1. Lipid species were determined by lipidomic analysis. Insulin sensitivity was scored by Akt phosphorylation and glucose transporter 4 (GLUT4) translocation, while pro-inflammatory indices were estimated by IκBα degradation and cytokine expression. Palmitate, but not palmitoleate, had mild effects on Akt phosphorylation but significantly inhibited insulin-stimulated GLUT4 translocation and increased expression of pro-inflammatory cytokines

Indexed as

Insulin ResistanceSignal TransductionAnimalsFatty AcidsGlucose Transporter Type 4InflammationMuscle Fibers, SkeletalMusclesNF-kappa BPalmitic AcidProtein TransportRatsSphingolipidsFatty AcidsGlucose Transporter Type 4NF-kappa BPalmitic AcidSphingolipidsceramidesglucose transporter 4inflammationlipidomics

Identifiers

PMID29794037
PMCPMC6027910
OpenAlexW2804925037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.